🇺🇸 FDA
Patent

US 10028946

Treating pain in patients with hepatic impairment

granted A61KA61K31/485A61K9/0053

Quick answer

US patent 10028946 (Treating pain in patients with hepatic impairment) held by Pernix Ireland Pain Designated Activity Company expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pernix Ireland Pain Designated Activity Company
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/485, A61K9/0053, A61K9/1676, A61K9/4808